70 results
Page 3 of 4
424B4
slp54oevsihpgasz
17 Jun 21
Prospectus supplement with pricing info
4:31pm
8-K
EX-1.1
8zw2 2mr9zxpnml3qv
16 Jun 21
Inhibikase Therapeutics Prices Follow-On Public Offering of Common Stock
9:20am
DRS
65ik03tkbq0 lj
2 Jun 21
Draft registration statement
12:00am
DRS
EX-1.1
h89ufa
2 Jun 21
Draft registration statement
12:00am
10-Q
da91pvb69lubhg8gdf
17 May 21
Quarterly report
4:41pm
DEF 14A
j6mcmqvjky2 drzj
30 Apr 21
Definitive proxy
5:20pm
10-K
cw6kvatfw66xgeaplh6
31 Mar 21
Annual report
2:14pm
8-K
EX-3.1
gx12x y4reozr2t
29 Dec 20
Inhibikase Therapeutics, Inc. Announces Pricing of its Initial Public Offering
4:38pm
424B4
xf9of
28 Dec 20
Prospectus supplement with pricing info
6:04am
S-1
EX-10.9
kwtmyos
23 Jul 20
IPO registration
12:28pm
S-1
0ri11yjd
23 Jul 20
IPO registration
12:28pm
S-1
EX-10.6
pj1kye1
23 Jul 20
IPO registration
12:28pm